These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 20980798)

  • 1. Assessment of HPV vaccines: from the burden of disease to the health technology assessment approach.
    La Torre G
    Hum Vaccin; 2010 Nov; 6(11):915-7. PubMed ID: 20980798
    [No Abstract]   [Full Text] [Related]  

  • 2. Do HPV vaccine genotypes agree with circulating HPV types?
    Tartaglia E; Iafusco D; Galderisi A; Mastrantonio P
    Lancet Infect Dis; 2011 Aug; 11(8):585-6. PubMed ID: 21798460
    [No Abstract]   [Full Text] [Related]  

  • 3. Genital HPV types in Australia.
    Brotherton J; Garland S; Donovan B
    Lancet Infect Dis; 2012 Feb; 12(2):102-3. PubMed ID: 22281139
    [No Abstract]   [Full Text] [Related]  

  • 4. Up to date: comprehensive knowledge of human papillomavirus.
    Park JS; Hur S
    Expert Rev Vaccines; 2013 Apr; 12(4):353-5. PubMed ID: 23560916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HPV 16/18 prevalence reduced 3 years following vaccine introduction.
    Riedmann EM
    Hum Vaccin Immunother; 2014; 10(2):254. PubMed ID: 24963520
    [No Abstract]   [Full Text] [Related]  

  • 6. Assessment of herd immunity from human papillomavirus vaccination.
    Bogaards JA; Berkhof J
    Lancet Infect Dis; 2011 Dec; 11(12):896; author reply 896-7. PubMed ID: 22115067
    [No Abstract]   [Full Text] [Related]  

  • 7. Human papillomavirus vaccination in HIV-infected women: need for increased coverage.
    Kojic EM; Rana AI; Cu-Uvin S
    Expert Rev Vaccines; 2016; 15(1):105-17. PubMed ID: 26599305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Health Technology Assessment of bivalent HPV vaccine Cervarix in Italy.
    La Torre G; de Waure C; Chiaradia G; Mannocci A; Capri S; Ricciardi W
    Vaccine; 2010 Apr; 28(19):3379-84. PubMed ID: 20197141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physician attitudes and practice toward human papillomavirus vaccination.
    Ko EM; Missmer S; Johnson NR
    J Low Genit Tract Dis; 2010 Oct; 14(4):339-45. PubMed ID: 20885162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Considerations for human papillomavirus (HPV) vaccination of mid-adult women in the United States.
    Grant LA; Dunne EF; Chesson H; Markowitz LE
    Vaccine; 2011 Mar; 29(13):2365-70. PubMed ID: 21277406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HPV vaccines: what remains to be done? Interview by Lauren Constable.
    Zur Hausen H
    Expert Rev Vaccines; 2011 Nov; 10(11):1505-7. PubMed ID: 22043949
    [No Abstract]   [Full Text] [Related]  

  • 12. Extended coverage of HPV vaccination in middle-aged adults to prevent oropharyngeal cancers.
    Arya SC; Agarwal N
    Hum Vaccin Immunother; 2012 Jul; 8(7):959. PubMed ID: 22777098
    [No Abstract]   [Full Text] [Related]  

  • 13. Benefits of vaccinating young adult women with a prophylactic quadrivalent human papillomavirus (types 6, 11, 16 and 18) vaccine.
    Monsonego J; Cortes J; Greppe C; Hampl M; Joura E; Singer A
    Vaccine; 2010 Nov; 28(51):8065-72. PubMed ID: 20971114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human papillomavirus vaccines: an update for gynecologists.
    Ault KA
    Clin Obstet Gynecol; 2008 Sep; 51(3):527-32. PubMed ID: 18677145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human papillomavirus infection and related cancers in sub-Saharan Africa: burden and tools for prevention.
    Awolude OA; Morhason-Bello IO; Denny LA; Adewole IF
    Vaccine; 2013 Dec; 31 Suppl 5():vii-x. PubMed ID: 24331751
    [No Abstract]   [Full Text] [Related]  

  • 16. Non-preventive care: challenges and opportunities for adolescent HPV vaccination.
    Vadaparampil ST; Perkins R
    Hum Vaccin Immunother; 2014; 10(9):2557-8. PubMed ID: 25483473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction in HPV prevalence--no evidence to support HPV vaccination reduces HPV prevalence.
    Groner JA; Harris GD; Harper DM
    J Infect Dis; 2014 Apr; 209(8):1302-4. PubMed ID: 24368836
    [No Abstract]   [Full Text] [Related]  

  • 18. Progress in the research on HPV vaccination: updates from the 25th International Papillomavirus Conference in Malmo, Sweden, 2009.
    Bonanni P; Boccalini S; Bechini A
    J Prev Med Hyg; 2009 Sep; 50(3):131-4. PubMed ID: 20499474
    [No Abstract]   [Full Text] [Related]  

  • 19. Towards cervical cancer eradication: joint force of HPV vaccination and HPV-based cervical cancer screening.
    Poljak M
    Clin Microbiol Infect; 2015 Sep; 21(9):806-7. PubMed ID: 26068650
    [No Abstract]   [Full Text] [Related]  

  • 20. Monitoring HPV vaccine impact: early results and ongoing challenges.
    Hariri S; Markowitz L
    J Infect Dis; 2012 Dec; 206(11):1633-5. PubMed ID: 23087429
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.